The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update

References

• Pavlou MP, Diamandis EP. The cancer cell secretome: a good source for discovering biomarkers? J Proteomics. 2010;73(10):1896–1906.
   PubMed Web of Science ®Google Scholar
• Cramer DW, O’Rourke DJ, Vitonis AF, et al. CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clin Chem. 2010;56(12):1889–1892.
   PubMed Web of Science ®Google Scholar
• Oppenheim JJ. The future of the cytokine discipline. Cold Spring Harb Perspect Biol. 2018 Sep 4;10(9). pii: a028498. doi: 10.1101/cshperspect.a028498. Review.PMID: 28847901.
   Google Scholar
• Burz C, Pop VV, Buiga R, et al. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget. 2018;9(36):24561–24571.
   PubMedGoogle Scholar
• Heitzer E, Ulz P, Geigl JB. Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem. 2015;61(1):112–123.
   PubMed Web of Science ®Google Scholar
• Ferracin M, Lupini L, Mangolini A, et al. Circulating non-coding RNA as biomarkers in colorectal cancer. Adv Exp Med Biol. 2016;937:171–181.
   PubMed Web of Science ®Google Scholar
• Ishiba T, Hoffmann AC, Usher J, et al. Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types. Biochem Biophys Res Commun. 2018;500(3):621–625.
   PubMed Web of Science ®Google Scholar
• Lucchetti D, Fattorossi A, Sgambato A. Extracellular vesicles in oncology: progress and pitfalls in the methods of isolation and analysis. Biotechnol J. 2018 Jun 7:e1700716. doi: 10.1002/biot.201700716. [Epub ahead of print] Review.PMID: 29878510.
   Google Scholar
• Hanash S. The wide world of molecular profiling for tumor classification. Clin Chem. 2018;64(4):743–744.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383.
   PubMed Web of Science ®Google Scholar
• Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol. 2016;36(3):301–312.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol. 2018 Feb;35:69-79. doi: 10.1016/j.smim.2017.12.003. Epub 2017 Dec 27. Review.PMID: 29289420.
   Google Scholar
• Zhang H, Freitas D, Kim HS, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018;20(3):332–343.
   PubMed Web of Science ®Google Scholar
• Zijlstra A, Di Vizio D. Size matters in nanoscale communication. Nat Cell Biol. 2018;20(3):228–230.
   PubMed Web of Science ®Google Scholar
• Meehan B, Rak J, Di Vizio D. Oncosomes - large and small: what are they, where they came from? J Extracell Vesicles. 2016;5:33109.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy. Future Oncol. 2017;13(28):2583–2592.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Cao P, Teng Y, et al. Isolation, identification, and characterization of novel nanovesicles. Oncotarget. 2016;7(27):41346–41362.
   PubMedGoogle Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014 Aug 4;3. doi: 10.3402/jev.v3.24641. eCollection 2014.
   Google Scholar
• Boyiadzis M, Whiteside TL. The emerging roles of tumor-derived exosomes in hematological malignancies. Leukemia. 2017;31(6):1259–1268.
   PubMed Web of Science ®Google Scholar
• Atay S, Godwin AK. Tumor-derived exosomes: a message delivery system for tumor progression. Commun Integr Biol. 2014;7(1):e28231.
   PubMedGoogle Scholar
• Fanini F, Fabbri M Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: state of the art. Semin Cell Dev Biol. 2017;67:23–28.
   PubMed Web of Science ®Google Scholar
• Frediani JN, Fabbri M. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer. 2016;15(1):42.
   PubMed Web of Science ®Google Scholar
• Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883–891.
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804.
   PubMed Web of Science ®Google Scholar
• Hong CS, Funk S, Muller L, et al. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles. 2016;5:29289.
   PubMed Web of Science ®Google Scholar
• Hong CS, Sharma P, Yerneni SS, et al. Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia. Sci Rep. 2017;7(1):14684.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016;126(4):1216–1223.
   PubMed Web of Science ®Google Scholar
• Iero M, Valenti R, Huber V, et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008;15(1):80–88.
   PubMed Web of Science ®Google Scholar
• Wieckowski EU, Visus C, Szajnik M, et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009;183(6):3720–3730.
   PubMed Web of Science ®Google Scholar
• Szajnik M, Czystowska M, Szczepanski MJ, et al. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010;5(7):e11469.
   PubMed Web of Science ®Google Scholar
• Mrizak D, Martin N, Barjon C, et al. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells. J Natl Cancer Inst. 2015;107(1):363.
   PubMedGoogle Scholar
• Ludwig S, Sharma P, Theodoraki MN, et al. Molecular and functional profiles of exosomes from HPV+ and HPV- head and neck cancer cell lines. Front Oncol. 2018 Oct 12;8:445. doi: 10.3389/fonc.2018.00445. eCollection 2018.
   Google Scholar
• Ludwig S, Floros T, Theodoraki MN, et al. Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer. Clin Cancer Res. 2017;23(16):4843–4854.
   PubMed Web of Science ®Google Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177–182.
   PubMed Web of Science ®Google Scholar
• Theodoraki MN, Yerneni SS, Hoffmann TK, et al. Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients. Clin Cancer Res. 2018;24(4):896–905.
   PubMed Web of Science ®Google Scholar
• Theodoraki MN, Yerneni SS, Brunnner C, et al. Plasma-derived exosomes reverse epithelial-to-mesenchymal transition after photodynamic therapy of patients with head and neck cancer. Oncoscience. 2018 Apr 29;5(3-4):75-87. doi: 10.18632/oncoscience.410. eCollection 2018 Mar. PMID: 29854876.
   Google Scholar
• Theodoraki MN, Gooding WE, Ferris RL, et al. Plasma‐derived exosomes carrying CTLA‐4, PD‐1 and PD‐L1 in head and neck squamous cell carcinoma patients treated with immunotherapy is associated with disease outcome. J ImmunoTher Cancer. 2017;5(5 Suppl 2):P89.
   Google Scholar
• Wang Y, Sabbatino F, Wang X, et al. Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma. Methods Mol Biol. 2014;1102:523–535.
   PubMedGoogle Scholar
• Sharma P, Ludwig S, Muller L, et al. Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma. J Extracell Vesicles. 2018;7(1):1435138.
   PubMed Web of Science ®Google Scholar
• Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 2016;113(8):E968–E977.
   PubMed Web of Science ®Google Scholar
• Sharma P, Gooding WE, Ferrone S, et al. Functional analysis and potential clinical significance of melanoma cell-derived exosomes in melanoma patients’ plasma. J Clin Oncol Insights. Forthcoming 2018.
   Google Scholar
• Theodoraki MN, Hoffmann TK, Whiteside TL. Separation of plasma-derived exosomes into CD3((+)) and CD3((-)) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients. Clin Exp Immunol. 2018;192(3):271–283.
   PubMed Web of Science ®Google Scholar
• Whiteside TL, Demaria S, Rodriguez-Ruiz ME, et al. Emerging opportunities and challenges in cancer immunotherapy. Clin Cancer Res. 2016;22(8):1845–1855.
   PubMed Web of Science ®Google Scholar
• Yang KS, Im H, Hong S, et al. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy. Sci Transl Med. 2017;9:391.
   Web of Science ®Google Scholar